Phlow
  • About
    • Who We Are
    • Our Impact
    • Leadership
    • Careers
  • CDMO
  • Product Portfolio
  • U.S. Facilities
    • Industrial Footprint
    • SAPIR™
  • News
  • Collaborate
Select Page

Phlow Corp. Receives The U.S Department of Health and Human Services, Office of Small and Disadvantaged Business Utilization, Small Business Prime Contractor of the Year Award

2021, Press Releases, Updates From Phlow™

RICHMOND, Va., July 19, 2021 – The U.S. Department of Health and Human Services (HHS), recently announced that Phlow Corp. has been awarded the Office of Small and Disadvantaged Business Utilization (OSDBU), Small Business Prime Contractor of the Year Award. Phlow...

How Pharmaceutical Innovation is Transforming Petersburg

2021, Phlow™ in the News

A surge of fresh energy and opportunities are attracting new residents and businesses to Virginia’s Gateway Region. Here’s what it means for the area – and why you might want to come along for the ride. Source: Livability From targeted agents used in precision...

Phlow Corp. CFO Receives Virginia Business CFO Award

2021, Updates From Phlow™

Phlow is honored to announce that our CFO, Bob Mooney, has received the coveted Virginia Business CFO Award honoring chief financial executives in Virginia. For decades, Bob has served as one of the most prominent business and civic leaders not only in the...

Phlow Corporation Donates to Pleasants Lane Elementary in Petersburg

2021, Updates From Phlow™

Phlow Corporation was honored to present, alongside our partners, AMPAC Fine Chemicals, Civica Rx, and Virginia Commonwealth University Medicines For All Institute, a check for over $58,000 on June 17, 2021 to Pleasants Lane Elementary in Petersburg, Virginia to...

Phlow Corporation Supports Biden Administration Efforts to Strengthen the Pharmaceutical Supply Chain

2021, Press Releases, Updates From Phlow™

RICHMOND, Va.—Phlow Corp. recognizes the Biden Administration’s efforts to highlight the challenges facing our nation’s pharmaceutical supply chain and appreciates the extensive 100-Day Review which identifies the key features necessary to create a resilient and...
« Older Entries
Next Entries »

Recent Posts

  • Phlow Corp. Achieves Completion of Full-Scale Demonstration of Succinylcholine Chloride Active Pharmaceutical Ingredient (API) Production at its U.S. Metric Ton Facility
  • Phlow Corp. Expands Analytical Capabilities and Embraces Artificial Intelligence-Driven System, Ushering in a New Era of Modern Medicine Manufacturing in America
  • Phlow Corp. Achieves Key Milestone Toward Full Epinephrine Production — Made in America
  • JPEO-CBRND, in Partnership with HHS, Utilizes Interagency Agreement to Contract with Phlow Corporation to Provide Medical Countermeasures
  • Phlow Observes 4th Annual National Essential Medicine Shortage Awareness Day, Reaffirms Commitment to Protecting America’s Medicine Cabinet

Recent Comments

No comments to show.

WHY THIS MATTERS
JOIN US

+1 (804) 207-4893

[email protected]

424 Hull St., Suite 400
Richmond, VA 23224

MEDIA INQUIRIES

STAY CONNECTED

  • Follow
  • Follow
  • Follow

To report an adverse event or product complaint associated with Phlow Drug Products, please call (844) 708-2982.

Privacy Policy | Consent Preferences | Additional Resources & Policies